LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 336 of 535
Next
>>
>
8376 to 8400 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Foretinib	0.12	uM	LJP5	3	H11	72	hr	1097	3689	3925	0.9398	0.9336
BT-20	Foretinib	0.37	uM	LJP5	1	H10	72	hr	1097	1587	3735	0.4249	0.2322
BT-20	Foretinib	0.37	uM	LJP5	2	H10	72	hr	1097	1753	3877	0.4521	0.2934
BT-20	Foretinib	0.37	uM	LJP5	3	H10	72	hr	1097	1562	3925	0.3979	0.2117
BT-20	Foretinib	1.11	uM	LJP5	1	H09	72	hr	1097	1353	3735	0.3622	0.1259
BT-20	Foretinib	1.11	uM	LJP5	2	H09	72	hr	1097	1309	3877	0.3376	0.1017
BT-20	Foretinib	1.11	uM	LJP5	3	H09	72	hr	1097	1147	3925	0.2922	0.0244
BT-20	Foretinib	3.33	uM	LJP5	1	H08	72	hr	1097	1257	3735	0.3365	0.0799
BT-20	Foretinib	3.33	uM	LJP5	2	H08	72	hr	1097	1329	3877	0.3427	0.1109
BT-20	Foretinib	3.33	uM	LJP5	3	H08	72	hr	1097	1325	3925	0.3375	0.1080
BT-20	Foretinib	10	uM	LJP5	1	H07	72	hr	1097	943	3735	0.2525	-0.0822
BT-20	Foretinib	10	uM	LJP5	2	H07	72	hr	1097	978	3877	0.2522	-0.0612
BT-20	Foretinib	10	uM	LJP5	3	H07	72	hr	1097	1008	3925	0.2568	-0.0451
BT-20	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	1097	2949	3610	0.8168	0.7778
BT-20	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	1097	2989	3713	0.8049	0.7678
BT-20	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	1097	3107	3696	0.8405	0.8112
BT-20	AZD 5438	0.12	uM	LJP6	1	J05	72	hr	1097	2235	3610	0.6190	0.5129
BT-20	AZD 5438	0.12	uM	LJP6	2	J05	72	hr	1097	2137	3713	0.5754	0.4608
BT-20	AZD 5438	0.12	uM	LJP6	3	J05	72	hr	1097	2380	3696	0.6439	0.5556
BT-20	AZD 5438	0.37	uM	LJP6	1	J04	72	hr	1097	1308	3610	0.3623	0.1077
BT-20	AZD 5438	0.37	uM	LJP6	2	J04	72	hr	1097	1519	3713	0.4090	0.2031
BT-20	AZD 5438	0.37	uM	LJP6	3	J04	72	hr	1097	1541	3696	0.4169	0.2139
BT-20	AZD 5438	1.11	uM	LJP6	1	J03	72	hr	1097	966	3610	0.2676	-0.0715
BT-20	AZD 5438	1.11	uM	LJP6	2	J03	72	hr	1097	1013	3713	0.2728	-0.0444
BT-20	AZD 5438	1.11	uM	LJP6	3	J03	72	hr	1097	1088	3696	0.2943	-0.0048

|<
<<
Previous
Page 336 of 535
Next
>>
>
8376 to 8400 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)